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Abstract: Due to the recent demand for high-throughput cellular assays, a lot of efforts have been made
on miniaturization of cell-based biosensors by preparing cell microarrays. Various microfabrication
technologies have been used to generate cell microarrays, where cells of different phenotypes are
immobilized either on a flat substrate (positional array) or on particles (solution or suspension array)
to achieve multiplexed and high-throughput cell-based biosensing. After introducing the fabrication
methods for preparation of the positional and suspension cell microarrays, this review discusses the
applications of the cell microarray including toxicology, drug discovery and detection of toxic agents.
Keywords: cell-based biosensor; cell microarray; microfabrication; toxicology; drug discovery;
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1. Introduction
A biosensor is a bioanalytical device or system in which biomolecules such as nucleic acids,
proteins (enzymes or antibodies), and whole cells are used as the recognition elements. Biosensors
allow researchers to indirectly measure target analytes using biological receptors via well-understood
transducers. Although biosensor studies have primarily been focused on diabetes, they have
potential uses in numerous other areas such as drug screening, detection of chemical warfare agents,
environmental toxins, and pollutants; and monitoring of food safety [1,2].
Among various types of biosensor, cell-based biosensor that use living cells as the sensing element
have been developed rapidly for various applications. The key advantage of cell-based assay over
conventional bioassay based on nucleic acids and proteins is that it can provide functional information
as well as analytical information, where the former is the information about the physiological effect of
analytes on our bodies, and the latter is the information about how much of a specific substance is
present [3,4]. Although most of the cell-based assays are currently being carried out using well-plate
formats, a lot of efforts have been made to enhance the performance of cell-based assay systems by
means of miniaturization [5,6]. In order to miniaturize the cell-based assay system, cell microarray
have been fabricated via different microfabrication techniques, where thousands of cells are attached
either on a flat surface (planar or positional array) or on a particle (solution or suspension array) to
implement multiplex assays in a high-throughput manner [7–11]. Cell microarrays are eventually
combined with optical or electrical detection technologies and integrated into microfluidic systems to
monitor the changes in cellular behavior under the influence of the external environment.
In this article, we first give detailed introduction about the types of cellular microarrays that are
prepared with planar substrates, microparticles, or a biomimetic three-dimensional (3D) environment.
Then, we discuss the applications of cell microarrays such as drug screening and biosensor systems.
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2. Preparation of Cell Microarray
In cell microarrays, different types of cells can adhere and grow either on flat chip-like substrates
or on particles to implement multiplexed and high-throughput cell-based assays, where former is
called as positional arrays and the latter is suspension arrays (Figure 1) [12].
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micropattern was generated from the photoresist after ultraviolet (UV) light exposure through the 
photomask and developing process. Then, the micropatterned substrate was coated with cell-adhesive 
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2.1. Positional Arrays
Positional arrays are usually prepared by generating multiple cellular microspots on the planar
substrates. For example, a position l array can contain numerous spots of c lls on on glass
slide, and e ch spot is easily istinguished by (x, y) coordinates on the micr array. Positi nal cell
microarrays w re initially prepared by physical spotting of cells on substrat s [13,14]. Nonetheless,
ue to rece t advances in icroele tromechanical systems (MEMS) and their applications to bi logy,
surface-micropatterning proce ses such t - soft lithography are widely used to gen rate c ll
microarr ys on various substrates [15, 6].
Photolithography has been most extensively used for cell patterning due to its simple way
of producing such patterns. This review d crib s three ways to gen rate cellular mic opatterns
using photolithography. First, a cell microarray can be prepared by photop tterning and a lift-off
process, where the generated microp tterns act as templates as shown in Figure 2a. For xample,
a design d micropattern was generated from the photoresist after ultraviol t (UV) light exposure
thr ugh the photomask and developi g process. Then, the micropatterned substrat was coat d
with cell-adhesive proteins [17,18]. Finally, by lifting off the photoresist and incubating the substrate
with a cell solution, tec nologist can obtain the desired pattern of cells [19,20]. Th second method
represent the use of photoreactive groups such as yl azide and benzophenone as shown in
Figure 2b [21,22]. In this m thod, a substrate is covered with photoreactive molecules conjugated with
cell-adhesion proteins. A photopatterning process causes the covalent bo ing between substrates
and photoreactive groups only at UV-exposed ar s. After removal of any u reacted molecules
with a solvent and subsequent cell seeding, the desired cellular micropatter s are obtained [10,23,24].
The final method is the use of photo-cro slinkable hydrogel micropatterns based on the fact that
hydrogels are generally non-adhesive to proteins and cells [25,26]. The previous studies showed the
fabrication of hydrogel micropatterns using poly(ethylene glycol)-diacrylate (PEG-DA) on various
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substrates. When microwell-type hydrogel micropatterns were fabricated, cells selectively adhered to
the hydrogel-free region as shown in Figure 2c [27,28]. Besides the PEG hydrogel, other hydrogels such
as those based on hyaluronic acid and gelatin have been photopatterned and used to create cellular
micropatterns [29–31].
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Figure 2. Cell and protein patterning using photolithography: (a) Lift-off approach using photoresist 
template; (b) Photochemical fixation of biomolecules; (c) Using photopatterned hydrogel 
microstructures. 
Soft lithography, which involves soft elastomeric materials for pattern transfer, was developed 
by Whitesides and colleagues as an alternative to photolithography because soft lithography is more 
suitable for biological applications [11,32]. Currently, soft lithographic techniques such as 
microcontact printing (μ-CP) and microfluidic channels involving poly(dimethylsiloxane) (PDMS) 
are mostly used for cell patterning [33,34]. In the μ-CP method, micropatterned PDMS act as stamp 
that transfer the patterns of certain molecules onto the substrate. (Figure 3a) [35], and this method 
represents great producibility due to re-usable stamp unless it is not physically damaged. A number 
of the studies on the cell and protein patterning using μ-CP have involved the use of alkanethiols, 
HS(CH2)nX, which chemisorb on metal surfaces such as gold, and form self-assembly monolayers 
(SAMs) [36–38]. The capability to have various terminal groups (X) enables the alkanethiols to control 
the surface properties. If SAMs were terminated with oligo(ethylene glycol) or ethylene glycol, those 
surfaces become non-adhesive to cells and proteins [39,40]. The combination of μ-CP with 
Figure 2. Cell and protein patterning using photolithography: (a) Lift-off approach using photoresist
template; (b) Photochemical fixation of biomolecules; (c) Using photopatterned hydrogel microstructures.
Soft lithography, which involves soft elastomeric materials for pattern transfer, was developed
by Whitesides and colleagues as an alternative to photolithography because soft lithography is more
suitable for biological applications [11,32]. Currently, soft lithographic techniques such as microcontact
printing (µ-CP) and microfluidic channels involving poly(dimethylsiloxane) (PDMS) are mostly used
for cell patterning [33,34]. In the µ-CP method, micropatterned PDMS act as stamp that transfer the
patterns of certain molecules onto the substrate. (Figure 3a) [35], and this method represents great
producibility due to re-usable stamp unless it is not physically damaged. A number of the studies
on the cell and protein patterning using µ-CP have involved the use of alkanethiols, HS(CH2)nX,
which chemisorb on metal surfaces such as gold, and form self-assembly monolayers (SAMs) [36–38].
The capability to have various terminal groups (X) enables the alkanethiols to control the surface
properties. If SAMs were terminated with oligo(ethylene glycol) or ethylene glycol, those surfaces
become non-adhesive to cells and proteins [39,40]. The combination of µ-CP with alkanethiol-based
SAM can generate cell adhesive and non-adhesive microdomains on metal surfaces, which can control
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the position of cells and generate cellular micropatterns. The PDMS-based microchannels are also used
as a simple method for patterning various biological molecules [41,42] since each microchannels can
be filled with different solutions. Microchannels were formed by reversible sealing of micropatterned
PDMS with a substrate. When a small volume solution is dropped on the substrate near the channel
entrance, microchannels are filled with solutions via capillary forces (Figure 3b) and only microliters of
the solution is necessary to fill the microchannels [43–45]. Microchannels have been used to generate
cellular micropatterns on the various substrates. Here, cell adhesive protein patterns were firstly
created on surfaces by introducing cell-adhesion proteins such as fibronectin and collagen into the
microchannels [46,47]. After removal of PDMS molds, patterned substrates are seeded with cells
so that the cells adhere only to the patterned proteins. By introducing various cell types through
different channels, a micropattern consisting of different cell types may also be easily generated on
surfaces [48–50], allowing multiphenotypic observation on a single plane.
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Figure 3. Schematic illustration of soft lithographic techniques for micropatterning: (a) Microcontact 
printing; (b) Microfluidic patterning; (c) Laminar flow patterning [11]. 
Due to the small dimension of microfluidic systems, the solution inside microchannels moves as 
a laminar flow [51–53]. Therefore, when the solutions introduced from different inlet are merged into 
a single microchannel, each solution flows parallel to each other without mixing with turbulence, 
which can be used to generate micropatterns as shown in Figure 3c, for example, if each solution 
contains different proteins [54,55]. 
In addition to photo- and soft lithography, which passively direct cell attachment by means of 
cell adhesive and non-adhesive microdomains, cellular micropatterns can be generated by 
Figure 3. Schematic illustration of soft lithographic techniques for micropatterning: (a) Microcontact
printing; (b) Microfluidic patterning; (c) Laminar flow patterning [11].
Due to the small dimension of microfluidic systems, the solution inside microchannels moves
as a laminar flow [51–53]. Therefore, when the solutions introduced from different inlet are merged
into a single microchannel, each solution flows parallel to each other without mixing with turbulence,
which can be used to generate micropatterns as shown in Figure 3c, for example, if each solution
contains different proteins [54,55].
In addition to photo- and soft lithography, which passively direct cell attachment by means of cell
adhesive and non-adhesive microdomains, cellular micropatterns can be generated by manipulation
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techniques where cells are positioned to specific location by applying external forces [56,57]. Although
various governing forces can be used to trap and localize cells, creating cellular micropatterns using
dielectrophoresis (DEP) have received much attention. The cell patterning using DEP has extensive
advantages such as the absence of the cell pretreatment, good cyto-compatibility, large-scale parallel
functioning, high spatial resolution, and easy combination with other techniques, thus endowing the
excellence of DEP in handling a lot of living cells at a time [58–61]. For example, Tsutsui et al. applied
DEP to cell patterning. DEP causes a motion of polarized cells through non-uniform electric fields, and
by means of patterned microelectrode arrays, more purified configuration can be obtained (Figure 4) [62].
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still a possible disadvantage of QDs as a source of optical fluorescence because of their toxicity. To 
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2.2. Suspension rrays
lthough positional arrays have been ell established and idely applied for high-throughput
assays, suspension arrays are rising as n alternative microa ray format because it is believ d that they
have greater flexibility than positional arrays in terms of multiplexity [63,64]. In the case of positional
microarr ys, patte ning of different cells on stand-al e substrates i difficult an req ires a complex
process. Howev r, with suspens on arrays, multiplex assay systems can be asily achieved by simply
mixing the independ ntly repared microparticles carrying diffe ent cells. In this case, the identity of
the cells is determined by s lf-encoded microparticles that ontain th cells as array component, instead
of x-y coordination on a planar surface [65–67]. Although a variety of strategies as been investig t d to
encod microparticl s, e.g., optical, electron , photophys , and graphical encoding, optically coded
spherical microp rticles are most commonly employed to realize the multiplexed assays in suspension
array formats [68–72]. For discr minatory ptical detection, mainly two types f encoding elements are
inc rporated i to microparticles: fluorescent dyes and quantum dots (QDs). The latter has become
alternative probes for suspension arrays inste d of usual flu rescent dyes owing to a wide excitation
wavel ngth, their high quantum yield, and excellent photostability compared with fluorescent dyes [73].
Figure 5 shows that the different color of QDs are embedded into microparticles with various ratios
to identify each particle [74]. However, there is s ll a possible disadvan ag of QDs as a source of
optic l fluorescence because of their toxicity. To avoid this problem, Zhao t l. and Deng et al. have
produced silica colloidal crystal beads (SCCBs) and silica photoni crystal microspheres (SPCM) a
carriers for t e suspension array (Figure 5b) [75,76]. Thei end products gen rally sha e the common
ideas: e.g., both groups have used si ica n noparticles as the fundamental material for microspheres.
The coding for these beads is a reflection f thei own structural periodicity, so they could avoid
bleach ng a d q enching of optical intensity, whereas chemi al instability is reduced.
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Therefore, in 2D system, cells exist in an unnatural environment and therefore, the cellular 
responses to external stimuli in a 2D microarray system might be different from those of cells in real 
tissues [90–92]. In order to minimize the difference between a cell-based assay and an animal study, 
there have been many efforts to create cell microarray in a biomimetic environment. One way to 
overcome the problems related with a 2D culture is to conduct cellular experiments in a biomimetic 
3D culture system, which has been mostly achieved by means of a hydrogel and nanofiber-based 
matrix [93,94].  
3.1. Hydrogel-Based 3D Cell Microarrays 
Among many types of biomaterials that have been fabricated to mimic ECM, hydrogel has 
become one of the excellent candidates for the particular purpose. With the emerging concept of 3D 
microarray systems, hydrogels have been used as a novel platform for cellular microarray 
applications. A hydrogel is a 3D hydrophilic crosslinked network made from water-soluble 
polymers. When placed in an aqueous solution, they tend to swell and retain a substantial amount of 
Figure 6. Graphically or shape-coded microarray: (a) Schematic diagram of the synthesis of bar-coded
hydrogel microparticles using flow lithography; (b) Fabrication of number-encoded micropallet array
with fibroblasts cultured on the surface of the array; (c) A suspension microarray of microboards that
contained multiple cell types (fibroblasts and HeLa cells), where each cell was identified by shape of
microboards (reproduced with permission from [83,85,87]).
3. Cell Microarrays in a Biomimetic Environment
In most cases of cell microarray preparation, cells are manipulated to adhere to a two-dimensional
(2D) substrate for both the positional and suspension array system. In a real in vivo environment,
cells are present in a 3D extracellular matrix (ECM) composed of a nanofibrous network whose
interfibrous space is filled with hydrogel-like materials consisting of proteins and polysaccharides as
shown in Figure 7 [88,89].
Sensors 2017, 17, 1293 7 of 27 
 
(c)
Figure 6. Graphically or shape-coded microarray: (a) Schematic diagram of the synthesis of bar-coded 
hydrogel microparticles using flow lithography; (b) Fabrication of number-encoded micropallet array 
with fibroblasts cultured on the surface of the array; (c) A suspension microarray of microboards that 
contained multiple cell types (fibroblasts and HeLa cells), where each cell was identified by shape of 
microbo rd (reproduced with permiss on from [83,85,87]). 
3. Cell Microarrays in a Biomimetic Environment 
In most cases of cell microarray preparation, cells are manipulated to adhere to a two-dimensional 
(2D) substrate for both the positional and suspension array system. In a real in vivo environment, 
cells are present in a 3D extracellular matrix (ECM) composed of a nanofibrous network whose 
interfibrous space is filled with hydrogel-like materials consisting of proteins and polysaccharides as 
shown in Figure 7 [88,89].  
 
Figure 7. Three-dimensional environments for cells in vivo (reproduced with permission from [89]). 
Therefore, in 2D system, cells exist in an unnatural environment and therefore, the cellular 
responses to external stimuli in a 2D microarray system might be different from those of cells in real 
tissues [90–92]. In order to minimize the difference between a cell-based assay and an animal study, 
there have been many efforts to create cell microarray in a biomimetic environment. One way to 
overcom  the problems related with a 2D culture is to conduct cellular xperiments in a biomimetic 
3D culture system, which has been mostly achi ved by means of a hydrogel and nanofiber-based 
matrix [93,94].  
3.1. Hydrogel-Based 3D Cell Microarrays 
Among many types of biomaterials that have been fabricated to mimic ECM, hydrogel has 
become one of the excellent candidates for the particular purpose. With the emerging concept of 3D 
microarray systems, hydrogels have been used as a novel platform for cellular microarray 
applications. A hydrogel is a 3D hydrophilic crosslinked network made from water-soluble 
polymers. When place  in an aqueous solution, they tend to swell and retain a substantial mount f 
Figure 7. Three-dimensional environments for cells in vivo (reproduced with permission from [89]).
Therefore, in 2D system, cells exist in an unnatural environme t and therefore, the cellular
responses to external stimuli in a 2D microarray system might be different from those of cells in real
tissues [90–92]. In order to minimize the difference between a cell-based assay and an animal study,
there have been many efforts to create cell microarray in a biomimetic environment. One way to
overcome the problems related with a 2D culture is to conduct cellular experiments in a biomimetic
3D culture system, which has been mostly achieved by means of a hydrogel and nanofiber-based
matrix [93,94].
3.1. Hydrogel-Based 3D Cell Microarrays
Among many types of biomaterials that have been fabricated to mimic ECM, hydrogel has
become one of the excellent candidates f r the particular purpose. With the emerging concept
of 3D microarray systems, hydrogels have been used as a novel platform for cellular microarray
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applications. A hydrogel is a 3D hydrophilic crosslinked network made from water-soluble polymers.
When placed in an aqueous solution, they tend to swell and retain a substantial amount of water
within [95–97]. Hydrogels have been widely used as biomaterials because of their high water content,
softness, pliability, biocompatibility, and easily controlled mass transfer properties that are essential
for allowing transport of nutrients to (and waste products from) the cell [98,99]. A hydrogel-based 3D
cell microarray is prepared by encapsulating mammalian cells inside a hydrogel microarray to mimic
the in vivo environment so that a more accurate response of cells to analytes can be obtained [100,101].
Cell encapsulation strategies usually involve homogenization of cells with gel precursors in a liquid
state followed by gelation through a crosslinking procedure [102,103]. Sugiura et al. fabricated
cell-encapsulating alginate hydrogel microbeads. Alginates are anionic polysaccharides and can form
hydrogels in the presence of multivalent cations such as Ca2+ (Figure 8a). Cells are resuspended
in a sodium alginate solution, and the droplets of the cell-containing alginate solution are injected
into a CaCl2 solution using a microinjection system to form hydrogel microbeads encapsulating
cells [104–106]. The Khademhosseini group used micromolding technique to generate cell-encapsulating
hyaluronic acid (HA) hydrogel microstructures (Figure 8b). Here, an acrylated HA solution containing
a cell suspension was exposed to UV light and became crosslinked, thus encapsulating cells [107].
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PEG-based hydrogels have also been widely used to create 3D cell microarrays. The physical
properties of PEG-based hydrogels can be easily controlled by varying the molecular weight of the PEG
molecules, and the transparent nature of PEG hydrogels also makes them suitable for various detection
schemes in biosensing applications [108–110]. Cell-encapsulating PEG microarrays can be prepared
by simple photolithography (Figure 9a) or via photoreaction injection molding (Figure 9b) [111].
In particular, photoreaction injection molding offers several advantages over the previously described
methods of encapsulating mammalian cells in hydrogel microstructures. For example, a small volume
of a cell-containing precursor solution is sufficient to fill and to photopolymerize inside a microchannel,
whereas cell patterning techniques based on spin-coating require a much larger volume of the precursor
solution because of a solution loss during the spin-coating procedure [112]. Another important
advantage of photoreaction injection molding is the possibility to encapsulate different phenotypes on
the same array as shown in Figure 9b because each microchannel can be independently filled with
a hydrogel precursor solution containing different cell types [113]. Because most of the hydrogels
do not support cell adhesion and growth, cell adhesion proteins or peptides were incorporated into
a hydrogel when cells were encapsulated within the hydrogels [114]. Although such cell-encapsulating
process could lead to substantial cellular damages, highly-adaptable in vivo condition of cells that
hydrogels provide is still inevitably appealing. Cell-encapsulating hydrogel microarrays were also
fabricated within microfluidic devices to realize lab-on-a-chip systems [115]. Microfluidic systems
offer several advantages, including decreased sample volume, fewer cells, shorter reaction time and
the ability to perform many experiments in parallel. Microfluidic devices are well suited for biological
experiments at the cellular level because microchannels within these devices can mimic the physical
size observed in vivo. Because of the small size of microchannels, microfluidic devices also enable
adequate oxygenation and fast nutrition diffusion. Such an environment helps cells to easily maintain
a local microenvironment (in contrast to macro-scale cell culture flasks) and to exist in a less stressful,
more in vivo-like surroundings, which can lead to more accurate data on cellular behavior in response
to external stimuli [116–120].
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While most of previous studies have discussed homogeneous network of hydrogels driven from
a single type of material, the hydrogel features can be advanced if two or more types of polymeric
materials are combined. This kind of hydrogels, so called the hybrid hydrogels, can take various
forms depending on the materials used, and usually these forms are achieved by combinations of
natural polymers and synthetic polymers, for example, alginate-poly-L-lysine(PLL), alginate-acrylate,
collagen-alginate, etc. [121]. Vlassak et al. has developed hybrid hydrogels with increased stiffness
and toughness for cartilage regeneration by combining alginate and polyacrylamide when forming
hydrogels [122]. Yarmush et al. has formed microencapsulation system with alginate-PLL hydrogels
to satisfy both cell viability and sufficient stiffness while supporting stem cell differentiation [123].
3.2. Nanofiber-Based Microarrays
Electrospun polymeric nanofiber scaffolds that have high porosity and a large surface area are
attractive substrates for cell patterning. Nanofiber can recapitulate characteristics of native cellular
microenvironments for in vitro cell cultures. Various cell types have been seeded onto electrospun
fibers, with the results indicating that fibrous structures have a more favorable influence on cell growth
than planar 2D surfaces do [124–128]. Although a lot of nanofiber-related studies have been reported,
most of them involve control of the properties of either the nanofiber itself (nanometer scale) or of the
macroscopic nanofiber matrix (millimeter or centimeter scale) [129,130].
Despite the extensive research that has been conducted on nanofiber and macroscopic
configurations of a nanofibrous matrix, only a few studies have shown implementation of
micropatterning electrospun nanofibers. For example, selective deposition of nonwoven mats using
collectors with microscopic electrode patterns may achieve dense nanofiber deposition within specific
microdomain (Figure 10a). Furthermore, electrospinning of photoreactive polymers and subsequent
photopatterning can generate spatially well-defined fibrous micropatterns (Figure 10b), whereas
multistep microcontact printing and etching techniques may be used to micropattern electrospun
fibers (Figure 10c) [131–134].
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Figure 10. Preparation f micropatterned nanofiber: (a) Se tive deposition of nanofiber us ng
the micropatterned electrodes; (b) Fabrication of micropatterned nanofiber using photopatterning;
(c) Schematic process flow of preparing nanofiber micropatterns via microcontact printing of fibers
deposited on a PDMS stamp and lithographic patterning of fibers on a PDMS stamp by using
photolithography and reactive ion etching tec niques (reproduced with permission from [131,132,135]).
Recently, Koh and colleagues fabricated positional and suspension types of cell microarrays using
a micropatterned nanofiber matrix which was prepared by combining PEG hydrogel lithography
and electrospinning (Figure 11a) [136]. For the positional cell microarray, microwell-shaped hydrogel
micropatterns were incorporated into nanofiber as shown in SEM image of Figure 11a [137]. Owing to
the non-adhesiveness of PEG hydrogels, cells selectively adhered onto the nanofiber region, creating
cellular micropatterns in a 3D environment (fluorescence image of Figure 11a) [138]. For a suspension
cell microarray, a micropillar-shaped PEG hydrogel precursor solution was photopatterned in
the presence of nanofiber. Subsequent removal of the bare nanofiber yielded various shapes of
nanofiber-entrapped hydrogel microparticles as shown in Figure 11b [139,140]. When a cell suspension
was added to the precursor solution, the cells were encapsulated within hydrogel microparticles during
the crosslinking process and adhered onto nanofiber because of non-adhesiveness of the PEG hydrogel
(fluorescence image of Figure 11b) [141].
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Figure 11. Creation of cellular micropatterns using hydrogel-incorporated nanofiber matrix:
(a) Schematic diagram of preparing micropatterned fibrous scaffold by combining PEG hydrogel
lithography with electrospinning technique (left), and SEM image of resultant scaffold and fluorescence
image of cellular microarray (right); (b) Schematic illustration of preparing hydrogel microparticles
entrapping nanofibers (left), and optical images of different shapes of hydrogel microparticles
entrapping PCL nanofiber and side view of hydrogel microparticles encapsulating nanofiber-attached
fibroblasts (right) (reproduced with permission from [136,137,139]).
Nanofibers may be incorporated into microfluidic devices. Jiang et al. have proposed a facile
nanofibrous scaffolds arrayed with microfluidic channels, expanding the practicality of electrospun
nanofibers. A biocompatible nanofibrous sheet was electrospun on a glass slide with an array of holes,
and then a photoresist was cast on top followed by UV exposure. The resulting scaffold satisfied 3D
cellular growth on the microarrayed platform [142]. The difficulty with production of a nanofiber
matrix of uniform size and thickness and with handling small and thin nanofiber matrices may be
overcome by incorporating hydrogel micropatterns. The resultant hydrogel-framed nanofiber may be
integrated into microfluidic devices [143]. In addition to conventional 3D cell culture using hydrogel
or nanofibers, newly emerged 3D surface based on supramolecules, copolymers and porous silicon
has recently received great attention as a new substrate for 3D cell microarrays [144–146]. So far, we
introduced different methods to prepare cell microarray in 2D or 3D environments and Table 1 lists the
advantages and disadvantages of each method.
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4. Applications of Cell Microarrays
Cell-based microarrays are powerful analysis tools for high-throughput testing of many target
samples. Miniaturization allows the increase of assay throughput, reduction of reagent consumption
and the number of cells required, thus making microarray system attractive for a variety of analysis
such as drug discovery, biosensing, and toxicology. In those applications, cells in microarrays are
exposed to samples containing drugs, pathogens, pollutants and various biomolecules. Cellular
response against those external stimuli can be monitored through optical (fluorescence or absorbance)
or electrical (change of impedance or electrical potential) detection methods [3,147].
4.1. Toxicology
Evaluating the toxicology has been recognized as the important study since we were getting more
knowledge about the toxicity, harmfulness and the resultant adverse effect of various compounds.
In the field of toxicology, in vivo work using animal has an advantage over in vitro work in that it
takes into account the response of entire biological system to a chemical challenge. However, use of
living animals not only is expensive and cumbersome but also has ethical issue. Cell-based assay
was proposed as an alternative method to evaluate the potential toxicity of certain molecules [148].
Like other application, cell microarrays are necessary for high-throughput toxicity assay [149].
Toxicity assay is being mostly carried out by quantifying viable and dead cells within the microarray
after cells are exposed to environmental perturbation caused by target compounds. The changes of
optical and electrical signal induced by the decrease of viable cells are detected in cell-based toxicity
studies, which are classified into two methods depending on whether they are label-based or label-free
assay [149,150]. Label-based assays use colorimetric or fluorescent viability/cytotoxicity assay to
quantify the portion of living and dead cells for toxicity assessment, where the changes of color and
fluorescent signals from the cells before and after exposure to a certain compound result from the
difference in cell membrane permeability or metabolic activity between living and dead cells. The MTT
assay, which is most commonly used as viability assay, is an example of colorimetric assay measuring
cell metabolic activity. In this assay, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
is reduced to purple formazan by the enzymes within the cells. The reduction of MTT by intercellular
enzyme only occurs within the living cells, and dead cells cannot cause this change [151,152]. Therefore,
the absorbance of solubilized formazan is proportional to the number of cells. However, MTT assay
cannot be applied to cell microarray system since it measures the absorbance of supernatant containing
dissolved formazan. Another type of metabolic activity assay uses the fluorescent reporter such as
fluorescein diacetate and calcein AM, which are initially colorless and non-fluorescent molecules
but converted into fluorescent molecules such as fluorescein and calcein, respectively once they are
hydrolyzed by esterase enzymes inside cells [153,154]. Dead cells cannot carry out this conversion
and consequently, fluorescence intensity from resultant fluorescein or calcein are related with the
viability of cells. Figure 12a shows that green fluorescence intensity from calcein decreased when cells
in microarrays were exposed to the toxic molecules [139]. Since produced fluorophores are trapped
inside the cell, this assay is applicable to cell microarray by allowing in-situ monitoring of fluorescence
intensity from the cells in each microarray spot.
In the case of viability assays based on membrane permeability, trypan blue or naphthalene black
are used as colorimetric reporters, which are originally membrane-impermeable dye but can permeate
into impaired cell membrane of dead cells and stain cytoplasm of dead cells [155]. Fluorescence-based
assays can be also used by addressing membrane integrity [156,157]. One example is a Live/Dead
viability/cytotoxicity fluorescence assay that uses SYTO10 and Dead Red as fluorophores to distinguish
living cells and dead cells. SYTO 10 stains living cells green and Dead Red stains dead cells red
based on the difference in the membrane integrity between living cells and dead cells as shown in
Figure 12b [158].
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Figure 12. Change in fluorescence intensity representing cell viability: (a) Fluorescence image
and graphical data of fibroblasts survival depending on various concentration of sodium azide;
(b) Observation of cellular viability depending on various concentration of silver nanoparticles (AgNPs)
feed to NIH 3T3 cells. (reproduced with permission from [139,158]).
On the other hands, lactate dehydrogenase (LDH) assay detects the LDH activity released
from the cells with damaged membranes [159,160]. Since this method measures the fluorescence or
absorbance of supernatant in extracellular space, it cannot be easily incorporated with cell microarray
like MTT assay.
Label-free assays usually monitor the changes in cell shape and morphology induced by external
stimuli such as toxin or drugs. Various microscopic techniques were proven to be suitable to
carry out phenotypic screening of cells on cell microarrays. Non-imaging tools such as surface
plasmon resonance (SPR) or resonant waveguide grating also demonstrated their capability to
monitor stimuli-mediated cellular response [161–163]. Both devices detect the changes of optical
properties caused by mass redistribution within the cells associated with morphology changes external
stimuli. However, there are still challenges in integrating these devices with cell microarray formats.
Furthermore, all the cells should be cultured in close proximity to the sensor surfaces since these
methods are effective only within 200 nm from the surface, which disables the cell-based assay using
3D cellular spheroids. Another label-free assay is electrochemical impedance measurement, which is
also called as electric cell-substrate impedance sensing (ECIS) [164,165]. In order to utilize this method
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for cell microarray, cells are cultured on the array of gold electrodes, the electrical impedance of which
is influenced by cell morphology change since the extracellular ionic current pathways are altered
by any changes in cell morphology. Electrically excitable cells such as neurons and cardiomyocytes,
which can generate different electrical signals with compounds and concentration dependent manners,
can be cultured on the microelectrode array and have been also used as label-free assay by recoding
the electrical signals [166–168]. Because of beating characteristics, cardiomyocyte can be also used as
label-free assay by recording the change of beating interval by external stimuli.
4.2. Drug Discovery
Cell-based microarray assays have become an essential procedure for drug discovery because
these methods are exceptionally useful for evaluating possible drug candidates with vast parallelism.
Throughout history, the overall libraries of chemicals and genetic collections have been continuously
expanding, which have driven the need for improved cell-based drug discovery screening technology.
In the beginning, such experiments were conducted in microtiter plates, which were provided in
96-well and up to 1536-well formats. However, with the introduction of cell microarrays, the situation
has improved dramatically, allowing for tens of millions of simultaneous assays in a single step.
In addition, with an extremely scaled-down assay, only small amounts of reagents and samples are
required; therefore, improved financial characteristics are guaranteed [6,8,169].
For further enhancement of miniaturized devices for a drug screening system, the cell microarray
should be integrated with a microfluidic maintenance complex. A microfluidic device consists of
a platform patterned with micro-scale channels to ensure a fluidic movement. This combined cell-based
biosensor is now becoming a dominant tool for chemical and drug screening. The implementation of
microfluidic systems is advantageous over a plain drug screening as mentioned earlier. Although a cell
microarray system provides outstanding conditions for drug screening, there is one problem that is
worth considering: reproduction of cell-cell interactions observed in living organisms. For in vitro
studies, researchers normally deal with homogeneous groups of cell types, but in real living organisms,
there are active interactions among different types of tissues. Therefore, toxic reactions in some tissue
types could also be affected by metabolic activities of other surrounding tissues, and drug screening of
different tissues in isolation will not yield reliable results. This limitation may be resolved by creating
a microsystem with interconnected space using a microfluidic system, where each capacity hosts
different cell types while the same screening is being conducted overall. Because the novel concept of
a “lab-on-a-chip” has become popular in biological research fields these days, this combined system
will definitely contribute to the idea. An “organ-on-a-chip” can be accomplished too, allowing for
examination of organ-like behaviors on a chip-based system [170–173].
For the successful high throughput drug screening system, controlled delivery of different drug
candidates into cells microarray can be achieved by various method including drug patterning,
stamping and microfluidic loading [174]. Bailey et al. utilized drug patterning method by
generating microarray of drug-embedded biodegradable polymer [175]. Cells were seeded onto
the microarrays and interacted with drug candidates that were slowly released from biodegradable
polymer micropatterns. Researchers could carry out synthetic lethal screen of 70 compounds with
A549 or HeLa cells by using a calcein acetoxymethyl ester fluorescence viability assay. The drug
screening systems using stamping method have two different microarray chips; one is cell microarray
and the other is drug-loaded chip. These two chips were aligned and sandwiched so that each cell spot
is exposed to one target drug or drug combination, which consequently prevent crosstalk between
neighboring assays. Khademhosseini group developed a sandwich drug screening platform [176].
In their system, cell microarray was prepared with PEG hydrogel microwells and drugs were loaded
onto the array of PDMS post. These two chips were sealed together so that each microwell is addressed
by a single drug-loaded PDMS post as shown in Figure 13.
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Figure 13. Fabrication of a microarray platform through sandwich system: (a) Schematic representation
of the fabrication process; (b) PDMS posts; (c) Microwells; (d) Optical microscopy image of the
cancer cells seeded within microwells; (e) Magnified optic and fluorescent image of the seeded cells;
(f) Numeric data of seeded cells per well depending on the seeding density; (g) A photograph of the
PDMS posts (left) and the microwell (right); (h) A photograph of the sandwiched system (reproduced
with permission from [176]).
The resultant microarray system was able to carry out screening of 320 drug candidates for
potential anti-cancer agents by using cytotoxicity assay with MCF-7 human breast cancer cells.
Kwon’s group proposed different stamping method by sandwiching particle chip and cell chip [177].
Unique feature of this system is the encoded drug-loaded hydrogel microparticles that were inserted
into microwells. The loaded drug was easily identified by the codes on the hydrogel microparticles
and released to the cells as shown in Figure 14a.Sensors 2017, 17, 1293 17 of 27 
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In this system, multiple drug-embedded microparticles could be loaded into a single microwell in
particle chip, enabling the generation of various combination of different types and concentrations
of drugs and the investigation of their effects on the cells with high-throughput manner (Figure 14b).
Microfluidic system has also been used to deliver the drugs in high-throughput cell-based screening
system since different drugs can be independently introduced to cell microarray through different
microchannels and a wide range of drug concentration can be generated using passive mixing
system [178]. For example, Jarayaman et al. developed microfluidic cell-based microarray integrated
with the drug delivery system capable of generating different concentration of two different drugs [179].
Yu et al. also developed microfluidic hepatocyte cell-based microchip where the multiple channels
integrated with concentration gradient generator allow the simultaneous administration of different
drug candidates or different concentrations of a drug candidate to hepatocytes [180].
4.3. Biosensor for Pathogens and Toxins
Conventionally, biosensors for detecting environmental threats like pathogens and toxins are
carried out using enzyme, antibody or nucleic acid as probe molecules, which rely on molecular
recognition for proper identification and quantification of a particular target. However, those methods
provide only analytical information without giving functional information, that is, effects of targets on
biological and physiological systems in our body [181–183]. Furthermore, those biosensors can
be only used for the detection of known target since their detections are based on the specific
interaction between probe molecules and target, where one probe molecules are specifically designed
or chosen for one target molecule. Therefore, conventional biosensors cannot be used for detection of
newly-developed chemical and biological warfare weapons.
In the past, living animals have been used as real biosensors when people needed some insights into
unknown toxic molecules, because conducting a direct experiment on humans is dangerous. More than
one hundred years ago, canaries were used to detect toxic gases in coal mines. There is also a record of US
troops using chickens as a means of detection of warfare agents used in wars against Iraq [4,184]. However,
because of economic and ethical issues of using animals as sensing elements, there have been many
attempts at functional characterization of pathogens and toxicants using cell-based biosensors. Unlike
conventional sensing elements such as enzymes or antibodies, cells can respond to various compounds,
which enable them to detect unknown targets [185]. For example, if cell viability decreased after exposure
to unknown samples, it can provide the information that toxic components may be included within the
sample. As mentioned earlier, cell-based biosensors, which incorporate cellular components, represent
a distinct enhancement in terms of functional information [186]. For example, in a cell-based biosensor
system for pathogen detection, these types of assays not only indicate the presence of pathogens, but
they can also provide practical instructions about the pathogens such as mode of action of the pathogen
or toxin as well as biological and physiological host–pathogen interactions [187,188].
Cell-based detection of pathogens and toxins can be achieved via two different methods [184]. First
method is using cellular membrane receptors based on the fact that the interaction between cell and analyte
is initiated by the receptor-analyte binding. Rider et al. developed genetically engineered B cell lines,
which are capable of detecting pathogens using membrane incorporated pathogen-specific antibodies as
shown in Figure 15a [182,184,189]. Binding of pathogens to antibodies induced that make engineered B
cells to emit light. The measurement of photon count from emitted cells enabled the quantification of
specific pathogens. Virus-specific antibodies were also electro-inserted in the membrane of fibroblast
cells and the binding between virus and antibodies were monitored by the principle of the bioelectronic
recognition assay using microelectrodes [190]. Secondly, cell-based biosensing can be performed using
viability assay that evaluate cytotoxicity of pathogens or toxins. Various cytotoxicity/viability assays
described in toxicology sections have been utilized for cell-based assays. For example, exposure of viable
cells to pathogens or toxic agent caused the decrease of cell viability, which could be detected optically
or electrically. Campbell et al. used ECIS to monitor the infections virus since viral-induced cell death
caused impedance changes [191]. B-lymphocyte cells encapsulated in 3D collagen matrix were used for
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rapid detection of pathogens and toxins by detecting the intracellular enzyme released from damaged
cells [192]. The changes in beating frequency, amplitude, and duration of cardiomyocytes were also
used for the evaluation of different heavy metal toxicity as shown in Figure 15b [193–195], while neural
network on microelectrode arrays could be used for the quantification of toxic agents [196,197].
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5. Conclusions and Future Perspective
Cell-based biosensors constitute a promising field that has numerous applications ranging from
pharmaceutical screening to detection of pathogens and toxins. The trends toward miniaturization
of cell-based biosensors continue to spur the development of cell microarrays. Although most of the
cell microarrays are still being analyzed by means of a positional microarray system, a suspension
microarray and int gration of a cell mic oar ay with microfluidic devices have received much attention
owing to the ease of multipl xing as w ll as experi ental an e onomic efficiency. Furthermore,
cell microarrays are prepared in a biomimetic 3D environment such as a hydrogel and nanofiber
to minimize the difference between an animal study and a cell-based assay. Eventually, 3D cell
microarray should be combined with microfluidic system, enabling high-throughput screening of
bioactive agents for drug discovery as well as detection of pathogens and toxins. However, there are still
significant tech ical challenges to be address d for cell microarray to ext nd their applic tions and be
commercialized. First, cell-based sensing has low specificity since various toxic agents result in similar
cell damages. Incorporation of probe molecules such as antibodies into cell membrane can enhance
the specificity of cell-based assay. Second, cells are prone to be damaged by slight changes of external
environments, and therefore, most of cell-based assays are carried out in the laboratory. Using 3D cell
culture such as cell-encapsulating hydrogel may provide some protective environments to the cells as
well as biomimetic environments and enable the on-the-spot detection of various toxic agents. Unlike
proteins and nucleic acids in microarray formats, storing and packaging cell microarray require more
complicated technologies such as cryopreservation, which currently reduced cell viability. After those
technical issues are addressed, highly integrated cell-based microdevices will find various applications
in basic biomedical/pharmaceutical research and form a new market in biosensor-related industries.
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